eGOVA(SZ:300075)2020-10-27 16:00Financial Performance - Operating revenue for the quarter was CNY 268,156,758.20, a 14.76% increase year-over-year, while year-to-date revenue decreased by 0.07% to CNY 754,688,730.72[12]. - Net profit attributable to shareholders surged by 195.05% to CNY 2,775,100.77 for the quarter, but decreased by 22.41% year-to-date to CNY 74,104,025.62[14]. - Basic and diluted earnings per share for the quarter were CNY 0.0020, a 100% increase, while year-to-date earnings per share decreased by 24.68% to CNY 0.1682[19][20]. - Total operating revenue for the current period reached ¥268,156,758.20, an increase from ¥233,677,145.20 in the previous period, representing a growth of approximately 14.8%[81]. - Net profit for the current period was ¥2,799,523.68, compared to ¥629,822.03 in the previous period, reflecting a significant increase of approximately 345.5%[87]. - The total comprehensive income for the current period was ¥2,799,523.68, significantly higher than ¥629,822.03 in the previous period, showing an increase of approximately 345.5%[90]. - Net profit for the current period is ¥73,892,886.06, down from ¥94,625,240.72 in the previous period, indicating a decrease of approximately 21.9%[101]. - The total comprehensive income for the current period is ¥73,892,886.06, down from ¥94,625,240.72, reflecting a decrease of approximately 21.9%[104]. Assets and Liabilities - Total assets increased by 21.12% to CNY 3,766,641,773.02 compared to the end of the previous year[9]. - Total liabilities decreased to ¥705,369,341.96 from ¥744,275,497.59, a reduction of about 5.2%[71]. - Total current assets reached ¥2,884,872,183.88, compared to ¥2,215,855,948.36 at the end of 2019, indicating a growth of approximately 30.1%[65]. - The total assets amounted to ¥3,109,817,326.14, an increase from ¥3,060,776,920.00, with a change of ¥49,040,406.14[143]. - Total liabilities decreased to CNY 721,249,411.20 from CNY 745,699,024.27, showing a reduction of CNY 24,449,613.07[131]. - Current liabilities totaled ¥604,436,925.30, down from ¥721,249,411.20, reflecting a decrease of approximately 16.2%[71]. - The company reported a total of ¥3,053,211,118.19 in equity attributable to shareholders, up from ¥2,354,372,357.19, representing an increase of approximately 29.6%[74]. Cash Flow - Net cash flow from operating activities increased by 244.96% to CNY 34,892,059.97 for the quarter[18]. - Cash and cash equivalents increased by 40.55% to ¥1,028,798,003.71 from ¥731,956,585.59 due to funds from a private placement[41]. - Cash flow from operating activities showed a net outflow of ¥104,885,799.95, improving from a net outflow of ¥122,529,963.98 in the previous period[114]. - Cash flow from investing activities resulted in a net outflow of ¥214,044,320.26, compared to a net outflow of ¥45,859,205.86 in the previous period[117]. - Cash flow from financing activities generated a net inflow of ¥638,092,953.63, a significant increase from a net outflow of ¥145,090,423.26 in the previous period[117]. Shareholder Information - The total number of ordinary shareholders at the end of the period was 44,405, with the largest shareholder holding 25.02%[27]. - The company did not engage in any repurchase agreements during the reporting period[30]. - The company has adhered to all commitments made regarding performance guarantees, including a net profit commitment of ¥8,000 million for 2020[50]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[60]. - There were no violations of external guarantee regulations during the reporting period[59]. Investments and Expenses - Investment income fell by 58.74% to -¥3,291,122.06 from -¥2,073,248.39, mainly due to decreased performance of associated companies[45]. - Research and development expenses for the current period were ¥30,133,605.07, slightly down from ¥30,501,240.26, indicating a decrease of about 1.2%[84]. - Research and development expenses increased to ¥52,430,317.18, up 9.73% from ¥47,817,997.52 in the previous period[108]. - The company reported a financial expense of -¥11,058,182.79, compared to -¥7,496,248.86 in the previous period, indicating an increase in financial costs[101].